EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Novel Sensitive Technique to Detect ESR1 Hotspot Mutations in Liquid Biopsy Using Switch‐Blocker–Enhanced Targeted Amplification Coupled With Pyrosequencing

Yantong Zhou, Wenna Wang iD, Bo Lan iD, Chunxiao Li, Jinsong Wang, Ting Wang, Fangzhou Sun, Yan Wang, Haili Qian, Fei Ma iD

Cancer Innovation · 2026-04 · 5 (2)

DOI: 10.1002/cai2.70054 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Innovation, online erschienen am 06.04.2026. Verfasst von Yantong Zhou und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Me…. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The detection of estrogen receptor 1 ( ESR1 ) ligand‐binding domain mutations in circulating tumor DNA (ctDNA) is crucial for guiding therapy in estrogen receptor‐positive metastatic breast cancer. However, widespread clinical adoption of approaches for monitoring drug resistance and guiding treatment decisions is hindered by limitations of current methods regarding sensitivity, cost, and multiplexing capability.

Methods

The application of switch‐blocker technology, which has been patented for detecting ESR1 hotspot mutations (Y537S/C, D538G, E380Q, and L536H/P), suppresses the amplification of wild‐type alleles while allowing specific amplification of low‐frequency mutant alleles. We used a switch‐blocker to inhibit the amplification of a DNA target approximately 10 base pairs in length (e.g., the switch‐blocker covering codon 536 of ESR1 targets various variants at positions 536, 537, and 538). Targeted enrichment was achieved by quantitative polymerase chain reaction, followed by pyrosequencing to confirm mutation components. Next‐generation sequencing and Sanger sequencing served as supplementary methods for the verification of results.

Results

The ESR1 ‐targeted DNA assay was validated for feasibility on plasmid circular templates and ctDNA linear templates. In tests using gradient‐diluted ESR1 plasmid templates, the proportion of L536H mutant copies increased from 0.0015% to 16.89% after targeted amplification, while the proportion of E380Q mutant copies increased from 0.0015% to 1.35%. In ctDNA samples previously analyzed by next‐generation sequencing, the switch‐blocker considerably enriched other mutant copies within the coverage range of the switch element.

Conclusions

This switch‐blocker–enhanced pyrosequencing assay presents a targeted, multiplexed, and accessible approach for detecting ESR1 hotspot mutations in liquid biopsies. This assay has potential for dynamic monitoring of therapeutic resistance, facilitating timely treatment decisions in advanced breast cancer management.

Schlagwörter

Stichwörter der Autor:innen

ESR1 mutationPCR amplificationbreast cancerendocrine therapy resistanceliquid biopsypyrosequencingswitch‐blocker

Autor:innen und Institutionen

  • State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China.
  • Department of Medical Oncology, National Cancer Center/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China.
  • McKusick-Zhang Center for Genetic Medicine, Institute of Basic Medical Sciences & School of Basic Medicine Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China.

ORCID-Profile: Wenna Wang, Bo Lan, Fei Ma

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhou, Y., Wang, W., Lan, B., Li, C., Wang, J., Wang, T., Sun, F., Wang, Y., Qian, H., & Ma, F. (2026). A Novel Sensitive Technique to Detect ESR1 Hotspot Mutations in Liquid Biopsy Using Switch‐Blocker–Enhanced Targeted Amplification Coupled With Pyrosequencing. Cancer Innovation, 5(2). https://doi.org/10.1002/cai2.70054

Vancouver

Zhou Y, Wang W, Lan B, Li C, Wang J, Wang T, et al. A Novel Sensitive Technique to Detect ESR1 Hotspot Mutations in Liquid Biopsy Using Switch‐Blocker–Enhanced Targeted Amplification Coupled With Pyrosequencing. Cancer Innovation. 2026;5(2). doi:10.1002/cai2.70054

BibTeX
@article{Zhou2026,
  author = {Zhou, Yantong and Wang, Wenna and Lan, Bo and Li, Chunxiao and Wang, Jinsong and Wang, Ting and Sun, Fangzhou and Wang, Yan and Qian, Haili and Ma, Fei},
  title = {A Novel Sensitive Technique to Detect ESR1 Hotspot Mutations in Liquid Biopsy Using Switch‐Blocker–Enhanced Targeted Amplification Coupled With Pyrosequencing},
  journal = {Cancer Innovation},
  year = {2026},
  volume = {5},
  number = {2},
  doi = {10.1002/cai2.70054}
}
Kostenlos starten →